In symptomatic HFrEF (LVEF ≤ 40%) who tolerate renin–angiotensin system blockade, ARNI is preferred over ACEi/ARB to reduce cardiovascular death and HF hospitalization; when switching from an ACE inhibitor, a 36 h washout is required [42]. Here, ACE is linked to hydrops fetalis.